Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

IPO/Stock Watch

Market trends, bell-weather stocks, filings and IPOs...

Hansoh Completes $1 Billion Hong Kong IPO; Rises 37% in First Trading Session

Frontage, a US-China CRO, Completes $205 Million Hong Kong IPO

Hansoh Seeks to Raise $1 Billion at Top of Hong Kong IPO Range

Mabpharm Hong Kong IPO to Raise $172 Million at $900 Million Valuation

Viva Biotech Completes $194 Million Hong Kong IPO; Trades Higher

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events


China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020